ArticleAmerican journal of respiratory and critical care medicine2022

Saracatinib, a Selective Src Kinase Inhibitor, Blocks Fibrotic Responses in Preclinical Models of Pulmonary Fibrosis.

Farida Ahangari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.